'Biomedical Innovation Can Come From Anywhere,' Says JNJ Innovation Head
Executive Summary
Richard Mason, head of Johnson & Johnson Innovation, London (EMEA), talks to Scrip senior writer, Lucie Ellis, about why R&D innovation hubs are still necessary to boost new scientific developments in the healthcare sector.